Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 6;11(1):9667.
doi: 10.1038/s41598-021-87838-z.

The heterogeneity of reversion to normoglycemia according to prediabetes type is not explained by lifestyle factors

Carolina Giráldez-García  1   2 , Lucía Cea-Soriano  3 , Romana Albaladejo  4 , Josep Franch-Nadal  1   5   6   7 , Manel Mata-Cases  1   8 , Javier Díez-Espino  1   9 , Sara Artola  1   10 , Rosario Serrano  1   11 , Enrique Regidor  1   4   12   13 ; PREDAPS Study Group
Collaborators, Affiliations

The heterogeneity of reversion to normoglycemia according to prediabetes type is not explained by lifestyle factors

Carolina Giráldez-García et al. Sci Rep. .

Abstract

Healthy lifestyle interventions and drug therapies are proven to have a positive preventative influence on normal glucose regulation in prediabetes. However, little is known on the specific role that these factors play on reversion to normal glycemia according to type of prediabetes. We used data from the Observational prospective cohort study, The Cohort study in Primary Health Care on the Evolution of Patients with Prediabetes from 2012 to 2015. A total of 1184 individuals aged 30-74 years old were included and classified based on the ADA in three mutually exclusive groups using either fasting plasma glucose (FPG) levels (from 100 to 125 mg/dl, FPG group), HbA1c (5.7-6.4%, HbA1c group) or both impaired parameters. Information on lifestyle factors and biochemical parameters were collected at baseline. Reversion to normal glucose regulation was calculated at third year of follow-up. Relationship of lifestyle factor and type of prediabetes with reversion were estimated using odds ratios (ORs) with 95% confidence intervals (95% CIs) adjusting by different groups of confounders. Proportion of reversion rates were 31% for FPG group, 31% for HbA1c group and 7.9% for both altered parameters group, respectively. Optimal life style factors such as BMI < 25 kg/m2[OR (95% CI): 1.90 (1.20-3.01)], high adherence to Mediterranean diet 1.78 (1.21-2.63) and absence of abdominal obesity 1.70 (1.19-2.43) were the strongest predictors for reversion to normal glucose. However, those did not modify the ORs of reversion to normal glucose. Taking as reference those with both impaired parameters, subjects with FPG impairment (FPG group) had an OR of 4.87 (3.10-7.65) and 3.72 (2.39-5.78) for HbA1c group. These estimates remained almost the same after further adjustment for biochemical parameters and lifestyle factors (4.55(2.84-7.28) and 3.09 (1.92-4.97), respectively). Optimal lifestyle factors showed to be a positive predictor for reversion to normal glucose regulation however, the differences of reversion risk according type of prediabetes are not explained by lifestyle factors.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
Proportion of patients reverting from prediabetes to normal glycaemia stratified by type of prediabetes.
Figure 2
Figure 2
Proportion of patients reverting from prediabetes to normal glycaemia stratified by type of prediabetes.
Figure 3
Figure 3
Proportion of patients reverting from prediabetes to normal glycaemia stratified by subtype of prediabetes.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. NCD Risk Factor Collaboration (NCD-RisC).Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4.4 million participants. Lancet387, 1513–1530 (2016). - PMC - PubMed
    1. Soriguer F, Goday A, Bosch-Comas A, Bordiú E, Calle-Pascual A, Carmena R, Casamitjana R, Castaño L, Castell C, Catalá M, Delgado E, Franch J, Gaztambide S, Girbés J, Gomis R, Gutiérrez G, López-Alba A, Martínez-Larrad MT, Menéndez E, Mora-Peces I, Ortega E, Pascual-Manich G, Rojo-Martínez G, Serrano-Rios M, Valdés S, Vázquez JA, Vendrell J. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: The diabetes study. Diabetologia. 2012;55(1):88–93. doi: 10.1007/s00125-011-2336-9. - DOI - PMC - PubMed
    1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442. doi: 10.1371/journal.pmed.0030442. - DOI - PMC - PubMed
    1. Perreault L, Kahn SE, Christophi CA, et al. Diabetes Prevention Program Research Group. Regression from prediabetes to normal glucose regulation in the diabetes prevention program. Diabetes Care. 2009;32:1583–1588. doi: 10.2337/dc09-0523. - DOI - PMC - PubMed
    1. Knowler WC, Barrett-Connor E, Fowler SE, et al. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002;346:393–403. doi: 10.1056/NEJMoa012512. - DOI - PMC - PubMed

Publication types